Articles with "nafld progression" as a keyword



Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in Mice

Sign Up to like & get
recommendations!
Published in 2022 at "Microbiology Spectrum"

DOI: 10.1128/spectrum.00047-22

Abstract: This study concentrates on longitudinal alternations of gut microbiota in NAFLD progression and discovers the interrelationships between them. These findings may uncover the role of gut microbiota in NAFLD progression and identify novel noninvasive diagnostic… read more here.

Keywords: nonalcoholic fatty; fatty liver; gut microbiota; disease ... See more keywords

NFATc1 signaling drives chronic ER stress responses to promote NAFLD progression

Sign Up to like & get
recommendations!
Published in 2022 at "Gut"

DOI: 10.1136/gutjnl-2021-325013

Abstract: Objectives Non-alcoholic fatty liver disease (NAFLD) can persist in the stage of simple hepatic steatosis or progress to steatohepatitis (NASH) with an increased risk for cirrhosis and cancer. We examined the mechanisms controlling the progression… read more here.

Keywords: stress; progression; stress responses; nafld progression ... See more keywords

NUSAP1 Could be a Potential Target for Preventing NAFLD Progression to Liver Cancer

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Pharmacology"

DOI: 10.3389/fphar.2022.823140

Abstract: Background: Non-alcoholic fatty liver disease (NAFLD) has gradually emerged as the most prevalent cause of chronic liver diseases. However, specific changes during the progression of NAFLD from non-fibrosis to advanced fibrosis and then hepatocellular carcinoma… read more here.

Keywords: liver; progression; degs; target preventing ... See more keywords

Targeting HMGCS2: Ketogenesis Suppression Accelerates NAFLD Progression in T2DM Comorbidity, While Cynaroside Ameliorates NASH in Concomitant T2DM

Sign Up to like & get
recommendations!
Published in 2025 at "Biomolecules"

DOI: 10.3390/biom15081181

Abstract: Patients with concurrent non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) exhibit increased susceptibility to non-alcoholic steatohepatitis (NASH), advanced hepatic fibrosis, cirrhosis, and hepatocellular carcinoma. This study investigated the contribution of ketogenesis… read more here.

Keywords: t2dm; hmgcs2; ketogenesis; nafld progression ... See more keywords